Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30


Benefits and harms of aspirin to reduce colorectal cancer risk: a cross-sectional study of methods to communicate risk in primary care.

Nguyen P, McIntosh J, Bickerstaffe A, Maddumarachchi S, Cummings KL, Emery JD.

Br J Gen Pract. 2019 Nov 28;69(689):e843-e849. doi: 10.3399/bjgp19X706613. Print 2019 Dec.


Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care.

McIntosh JG, Minshall J, Saya S, Bickerstaffe A, Hewabandu N, Qama A, Emery JD.

Br J Gen Pract. 2019 Nov 28;69(689):e836-e842. doi: 10.3399/bjgp19X706841. Print 2019 Dec.


The CRISP-P study: feasibility of a self-completed colorectal cancer risk prediction tool in primary care.

Harty EC, McIntosh JG, Bickerstaffe A, Hewabandu N, Emery JD.

Fam Pract. 2019 Nov 18;36(6):730-735. doi: 10.1093/fampra/cmz029.


Could an online or digital aid facilitate discussions about sexual health with older Australians in general practice?

Malta S, Temple-Smith M, Hunter J, McGavin D, Lyne J, Bickerstaffe A, Hocking J.

Aust J Gen Pract. 2018 Dec;47(12):870-875. doi: 10.31128/AJGP-04-18-4557.


Do you talk to your older patients about sexual health? Health practitioners’ knowledge of, and attitudes towards, management of sexual health among older Australians

Malta S, Hocking J, Lyne J, McGavin D, Hunter J, Bickerstaffe A, Temple-Smith M.

Aust J Gen Pract. 2018 Nov;47(11):807-811. doi: 10.31128/AJGP-04-18-4556.


Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis.

Jayasekara H, MacInnis RJ, Chamberlain JA, Dite GS, Leoce NM, Dowty JG, Bickerstaffe A, Win AK, Milne RL, Giles GG, Terry MB, Eccles DM, Southey MC, Hopper JL.

Int J Cancer. 2019 Dec 15;145(12):3207-3217. doi: 10.1002/ijc.32214. Epub 2019 Mar 5.


The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing.

Lo LL, Collins IM, Bressel M, Butow P, Emery J, Keogh L, Weideman P, Steel E, Hopper JL, Trainer AH, Mann GB, Bickerstaffe A, Antoniou AC, Cuzick J, Phillips KA.

JMIR Form Res. 2018 Nov 7;2(2):e24. doi: 10.2196/formative.9935.


Consumer and clinician perspectives on personalising breast cancer prevention information.

Keogh LA, Steel E, Weideman P, Butow P, Collins IM, Emery JD, Mann GB, Bickerstaffe A, Trainer AH, Hopper LJ, Phillips KA.

Breast. 2019 Feb;43:39-47. doi: 10.1016/j.breast.2018.11.002. Epub 2018 Nov 7.


The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.

Walker JG, Macrae F, Winship I, Oberoi J, Saya S, Milton S, Bickerstaffe A, Dowty JG, De Abreu Lourenço R, Clark M, Galloway L, Fishman G, Walter FM, Flander L, Chondros P, Ait Ouakrim D, Pirotta M, Trevena L, Jenkins MA, Emery JD.

Trials. 2018 Jul 25;19(1):397. doi: 10.1186/s13063-018-2764-7.


An open-source, integrated pedigree data management and visualization tool for genetic epidemiology.

Ranaweera T, Makalic E, Hopper JL, Bickerstaffe A.

Int J Epidemiol. 2018 Aug 1;47(4):1034-1039. doi: 10.1093/ije/dyy049.


The CRISP-Q study: Communicating the risks and benefits of colorectal cancer screening

Kim GY, Walker JG, Bickerstaffe A, Hewabandu N, Pirotta M, Flander L, Jenkins M, Emery JD.

Aust J Gen Pract. 2018 Mar;47(3):139-145. doi: 10.31128/AFP-04-17-4195.


Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer.

Dite GS, MacInnis RJ, Bickerstaffe A, Dowty JG, Milne RL, Antoniou AC, Weideman P, Apicella C, Giles GG, Southey MC, Jenkins MA, Phillips KA, Win AK, Terry MB, Hopper JL.

Am J Epidemiol. 2017 Mar 15;185(6):487-500. doi: 10.1093/aje/kww241.


The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care.

Walker JG, Bickerstaffe A, Hewabandu N, Maddumarachchi S, Dowty JG; CRECRC, Jenkins M, Pirotta M, Walter FM, Emery JD.

BMC Med Inform Decis Mak. 2017 Jan 19;17(1):13. doi: 10.1186/s12911-017-0407-7.


The Ark: a customizable web-based data management tool for health and medical research.

Bickerstaffe A, Ranaweera T, Endersby T, Ellis C, Maddumarachchi S, Gooden GE, White P, Moses EK, Hewitt AW, Hopper JL.

Bioinformatics. 2017 Feb 15;33(4):624-626. doi: 10.1093/bioinformatics/btw675.


iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management.

Collins IM, Bickerstaffe A, Ranaweera T, Maddumarachchi S, Keogh L, Emery J, Mann GB, Butow P, Weideman P, Steel E, Trainer A, Bressel M, Hopper JL, Cuzick J, Antoniou AC, Phillips KA.

Breast Cancer Res Treat. 2016 Feb;156(1):171-82. doi: 10.1007/s10549-016-3726-y. Epub 2016 Feb 24.


Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk.

Nguyen TL, Aung YK, Evans CF, Dite GS, Stone J, MacInnis RJ, Dowty JG, Bickerstaffe A, Aujard K, Rommens JM, Song YM, Sung J, Jenkins MA, Southey MC, Giles GG, Apicella C, Hopper JL.

Int J Epidemiol. 2017 Apr 1;46(2):652-661. doi: 10.1093/ije/dyw212.


Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry.

Dite GS, MacInnis RJ, Bickerstaffe A, Dowty JG, Allman R, Apicella C, Milne RL, Tsimiklis H, Phillips KA, Giles GG, Terry MB, Southey MC, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):359-65. doi: 10.1158/1055-9965.EPI-15-0838. Epub 2015 Dec 16.


Elevated plasma inflammatory mediators in post-polio syndrome: No association with long-term functional decline.

Bickerstaffe A, Beelen A, Lutter R, Nollet F.

J Neuroimmunol. 2015 Dec 15;289:162-7. doi: 10.1016/j.jneuroim.2015.10.019. Epub 2015 Nov 11.


Change in physical mobility over 10 years in post-polio syndrome.

Bickerstaffe A, Beelen A, Nollet F.

Neuromuscul Disord. 2015 Mar;25(3):225-30. doi: 10.1016/j.nmd.2014.11.015. Epub 2014 Nov 27.


Assessing and managing breast cancer risk: clinicians' current practice and future needs.

Collins IM, Steel E, Mann GB, Emery JD, Bickerstaffe A, Trainer A, Butow P, Pirotta M, Antoniou AC, Cuzick J, Hopper J, Phillips KA, Keogh LA.

Breast. 2014 Oct;23(5):644-50. doi: 10.1016/j.breast.2014.06.014. Epub 2014 Jul 4.


Quantitative muscle ultrasound and quadriceps strength in patients with post-polio syndrome.

Bickerstaffe A, Beelen A, Zwarts MJ, Nollet F, van Dijk JP.

Muscle Nerve. 2015 Jan;51(1):24-9. doi: 10.1002/mus.24272.


Loss of motor unit size and quadriceps strength over 10 years in post-polio syndrome.

Bickerstaffe A, van Dijk JP, Beelen A, Zwarts MJ, Nollet F.

Clin Neurophysiol. 2014 Jun;125(6):1255-60. doi: 10.1016/j.clinph.2013.11.003. Epub 2013 Nov 12.


Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer.

Meiser B, Price MA, Butow PN, Rahman B, Tucker K, Cheah B, Bickerstaffe A, Hopper J, Phillips KA.

Fam Cancer. 2014 Jun;13(2):153-62. doi: 10.1007/s10689-013-9687-y.


Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre.

MacInnis RJ, Bickerstaffe A, Apicella C, Dite GS, Dowty JG, Aujard K, Phillips KA, Weideman P, Lee A, Terry MB, Giles GG, Southey MC, Antoniou AC, Hopper JL.

Br J Cancer. 2013 Sep 3;109(5):1296-301. doi: 10.1038/bjc.2013.382. Epub 2013 Aug 13.


Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model.

Dite GS, Mahmoodi M, Bickerstaffe A, Hammet F, Macinnis RJ, Tsimiklis H, Dowty JG, Apicella C, Phillips KA, Giles GG, Southey MC, Hopper JL.

Breast Cancer Res Treat. 2013 Jun;139(3):887-96. doi: 10.1007/s10549-013-2610-2. Epub 2013 Jun 18.


Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians.

Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, Byrnes GB, Giles GG, Wallace AB, Anderson PR, Guiver TA, McGale P, Cain TM, Dowty JG, Bickerstaffe AC, Darby SC.

BMJ. 2013 May 21;346:f2360. doi: 10.1136/bmj.f2360.


Supercomputing enabling exhaustive statistical analysis of genome wide association study data: Preliminary results.

Reumann M, Makalic E, Goudey BW, Inouye M, Bickerstaffe A, Bui M, Park DJ, Kapuscinski MK, Schmidt DF, Zhou Z, Qian G, Zobel J, Wagner J, Hopper JL.

Conf Proc IEEE Eng Med Biol Soc. 2012;2012:1258-61. doi: 10.1109/EMBC.2012.6346166.


Circumstances and consequences of falls in polio survivors.

Bickerstaffe A, Beelen A, Nollet F.

J Rehabil Med. 2010 Nov;42(10):908-15. doi: 10.2340/16501977-0620.


Epidemiology and pathophysiology of falls in facioscapulohumeral disease.

Horlings CG, Munneke M, Bickerstaffe A, Laverman L, Allum JH, Padberg GW, Bloem BR, van Engelen BG.

J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1357-63. doi: 10.1136/jnnp.2009.173534. Epub 2009 Jun 21.


The crystalline structures of carboxylic acid monolayers adsorbed on graphite.

Bickerstaffe AK, Cheah NP, Clarke SM, Parker JE, Perdigon A, Messe L, Inaba A.

J Phys Chem B. 2006 Mar 23;110(11):5570-5.


Supplemental Content

Loading ...
Support Center